Dr. Dunnett Capdevilla Durando, DO

Dr. Durando practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Durando's NPI, 1275775322, was assigned on April 2, 2009. Dr. Durando holds Florida license OS12068.

Dr. Durando's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Durando's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. Dr. Durando is also affiliated with Cape Coral Hospital. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Durando to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Durando practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Durando's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Durando is board certified in dermatology by the AOA Board of Dermatology. Dr. Durando is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Durando treats.

CMS data shows 5,897 Medicare services from Dr. Durando across 31 procedure codes in 2024, for 1,346 Medicare patients. Medicare paid $371,479 for them. Every service was in an office.

CMS counts 1,346 Medicare patients who saw Dr. Durando in 2024. The largest group is 65 to 74, with 656 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Durando's median patient age at 75, with 58% women.

In 2024, Dr. Durando wrote 2,506 Medicare Part D claims for 959 patients. 89% of them were for generic drugs. CMS names the drug for 2,362 of them, across 37 drugs with 11 or more claims each, at $967,396 in total drug cost. In 2023, CMS named 2,353 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Durando for performance year 2024, reported as part of a group. Dr. Durando accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,379 procedures of removal of skin lesions by Dr. Durando, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Durando in 2014. Dr. Durando's most frequent co-authors are Ann Ammond Lafond, MD and Caitlin Flynn Porubsky, DO.

CMS Open Payments shows 656 general payments to Dr. Durando from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Amgen Inc. paid the most, $57,521.

Dr. Durando is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.